Kansas Masonic Cancer Research Center

Kansas City, Kansas 66160

0 studies enrolling now · 1 studies all time

What they study most

Advanced Cancer, Refractory Cancer

Studies at this site

• A Safety Study of an Oral EGFR Inhibitor, AV-412, Administered Three Times Weekly in Advanced Solid Tumor Patients — Completed